Development of sustainable and resilient healthcare and non-cold pharmaceutical distribution supply chain for COVID-19 pandemic: a case study

Omid Abdolazimi · Mitra Salehi Esfandarani · Maryam Salehi · Davood Shishebori · Majid Shakhsi‐Niaei

65 citations0/0 files storedThe International Journal of Logistics Management

No readable copy stored yet — this record is metadata only.

No open-access location is known for this record yet.

Literature note Cite in a project Citation map

Sustainable Supply Chain Management Supply Chain and Inventory Management Supply Chain Resilience and Risk Management

Abstract

Purpose This study evaluated the influence of the coronavirus pandemic on the healthcare and non-cold pharmaceutical care distribution supply chain. Design/methodology/approach The model involves four objective functions to minimize the total costs, environmental impacts, lead time and the probability of a healthcare provider being infected by a sick person was developed. An improved version of the augmented e-constraint method was applied to solve the proposed model for a case study of a distribution company to show the effectiveness of the proposed model. A sensitivity analysis was conducted to identify the sensitive parameters. Finally, two robust models were developed to overcome the innate uncertainty of sensitive parameters. Findings The result demonstrated a significant reduction in total costs, environmental impacts, lead time and probability of a healthcare worker being infected from a sick person by 40%, 30%, 75% and 54%, respectively, under the coronavirus pandemic compared to the normal condition. It should be noted that decreasing lead time and disease infection rate could reduce mortality and promote the model's effectiveness. Practical implications Implementing this model could assist the healthcare and pharmaceutical distributors to make more informed decisions to minimize the cost, lead time, environmental impacts and enhance their supply chain resiliency. Originality/value This study introduced an objective function to consider the coronavirus infection rates among the healthcare workers impacted by the pharmaceutical/healthcare products supply chain. This study considered both economic and environmental consequences caused by the coronavirus pandemic condition, which occurred on a significantly larger scale than past pandemic and epidemic crises.

Paper brief

Loading…

Cite this work

Citation unavailable for this work.

BibTeX RIS CSL-JSON

No public copy is stored for this record, so only the metadata is cited.

Citations in this library

Citation map →

Stored only when both papers are in the corpus — 65 citations exist upstream.

References

2006Perspectives in supply chain risk management 2020Predicting the impacts of epidemic outbreaks on global supply chains: A simulation-based analysis on the coronavirus outbreak (COVID-19/SARS-CoV-2) case 2020Viability of intertwined supply networks: extending the supply chain resilience angles towards survivability. A position paper motivated by COVID-19 outbreak 2005Managing Disruption Risks in Supply Chains 2006On the Value of Mitigation and Contingency Strategies for Managing Supply Chain Disruption Risks 2007The Severity of Supply Chain Disruptions: Design Characteristics and Mitigation Capabilities 2006Robust strategies for mitigating supply chain disruptions 2019Review of quantitative methods for supply chain resilience analysis

Cited by

2024Sustainable supply chain, dynamic capabilities, eco‐innovation, and environmental performance in an emerging economy 2022Modeling a sustainable vaccine supply chain for a healthcare system 2022Healthcare Supply Chain Management under COVID-19 Settings: The Existing Practices in Hong Kong and the United States 2023Enhancement the Performance of Multi-Level and Multi-Commodity in Supply Chain: A Simulation Approach

Explore the map →

Papers that cite the same references — the relational fallback while embeddings are still backfilling.

Imported from OpenAlex (CC0) — nothing here is generated.